K Osei

Author PubWeight™ 26.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001 1.45
2 Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1993 1.38
3 Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med 1987 1.06
4 Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 1996 1.03
5 Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med 1985 0.98
6 Differential impact of obesity on glucose metabolism in black and white American adolescents. Am J Med Sci 1998 0.93
7 Empyema due to Salmonella typhimurium with underlying alveolar cell carcinoma. South Med J 1984 0.92
8 Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care 1984 0.89
9 The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X. Diabetes Care 1997 0.88
10 Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM. Diabetes Res Clin Pract 2005 0.88
11 Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol 1986 0.88
12 Do sociodemographics and economic status predict risks for type II diabetes in African Americans? Diabetes Educ 1997 0.86
13 Facilities and resources for diabetes care at regional health facilities in southern Ghana. Diabetes Res Clin Pract 1998 0.85
14 The differential effects of body fat distribution on insulin and glucose metabolism during pregnancy. Am J Obstet Gynecol 1994 0.83
15 Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study. Heart 2005 0.83
16 Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med 1984 0.83
17 Effects of acute running exercise on whole body insulin action in obese male SHHF/Mcc-facp rats. J Appl Physiol (1985) 1994 0.82
18 Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes. Diabetes Obes Metab 2013 0.81
19 Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med 1983 0.80
20 Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab 1986 0.80
21 Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects. Ethn Dis 2001 0.79
22 Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin. Diabetes Obes Metab 2011 0.79
23 Hypoglycemia after successful pancreas transplantation in type I diabetic patients. Diabetes Care 1991 0.79
24 Cardiovascular effects of aging. Interrelationships of aortic, left ventricular, and left atrial function. Herz 2001 0.78
25 Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians. Diabetologia 2003 0.78
26 Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients. Diabet Med 1992 0.77
27 Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care 1999 0.77
28 Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med 1985 0.76
29 Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus. Ethn Dis 1998 0.76
30 The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism 2003 0.76
31 Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med 1986 0.75
32 Predicting type II diabetes in persons at risk. Ann Intern Med 1990 0.75
33 Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients. Metabolism 1987 0.75
34 Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care 1984 0.75
35 Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med 1986 0.75
36 Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care 1985 0.75
37 The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med 1991 0.75
38 Pancreatic allograft function as assessed by IMX first-phase insulin assays. Transplant Proc 1994 0.75
39 Abnormal retinal artery responses to stress in patients with type I diabetes. Am J Med 1985 0.75
40 Ambulatory and exercise-induced blood pressure responses in type I diabetic patients and normal subjects. Diabetes Res Clin Pract 1987 0.75
41 Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med 1984 0.75
42 The role of splanchnic glucose output in determining glycemic responses after mixed meal in type II diabetic patients and normal subjects. Pancreas 1987 0.75
43 Pregnancy complicated by insulinoma. Am J Med Sci 1984 0.75
44 The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia 1986 0.75
45 Case report: defective beta and alpha cell regulation in patients with hyperinsulinemia and acanthosis nigricans. Am J Med Sci 1994 0.75
46 Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care 1999 0.75
47 Clinical evaluation of determinants of glycemic control. A new approach using serum glucose, C-peptide, and body mass indexes in type II diabetic patients. Arch Intern Med 1986 0.75
48 Pancreatic exocrine "burnout" following pancreas transplantation. Transplant Proc 1992 0.75
49 Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J 1984 0.75
50 Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci 1985 0.75